(Bloomberg) -- Humana Inc. is in advanced talks to sell an arm of Kindred at Home to private equity firm Clayton Dubilier & Rice in a deal that would value the business at about $3 billion, according to people with knowledge of the matter. 

A deal between the health insurer and CD&R for the hospice, palliative and personal care business could be announced within days, said the people, who asked not to be identified because the information isn’t public. Humana plans to retain a stake in the business, the people said.

A final agreement hasn’t been reached and the talks could end without one, they added.

Humana inherited the hospice business last year when it acquired the portion of the home-health company it didn’t already own.

Representatives for Humana and CD&R didn’t respond to requests for comment.

Humana agreed last April to buy the 60% of Kindred at Home held by two private equity partners for $5.7 billion. At the time, Humana said it only planned to hold a minority interest in the hospice and community-care part of the business. The firm tapped Goldman Sachs Group Inc. to help it run a sales process for that business, the people said. 

Humana had acquired the company with the two firms, TPG and Welsh, Carson, Anderson & Stowe, in a $4.1 billion deal including debt announced in 2017, according to a statement at the time.

Kindred at Home is changing its name to CenterWell Home Health, according to its website.

©2022 Bloomberg L.P.